新产业收盘上涨2.71%，滚动市盈率25.13倍，总市值462.40亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Shenzhen New Industry Biomedical Engineering Co., Ltd. in the medical device sector, particularly in the in vitro diagnostics field [1][2] - As of August 15, the company's stock closed at 58.85 yuan, with a PE ratio of 25.13, marking a 46-day low, and a total market capitalization of 46.24 billion yuan [1] - The average PE ratio for the medical device industry is 56.58, with a median of 39.97, placing the company at the 50th position within the industry [1][2] Group 2 - The company reported a 2025 Q1 revenue of 1.125 billion yuan, reflecting a year-on-year increase of 10.12%, and a net profit of 438 million yuan, up 2.65% year-on-year, with a gross margin of 68.01% [1] - As of March 31, 2025, the number of shareholders increased to 19,269, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company has received accolades such as the "National Brand Gold Award" for medical equipment in 2024, indicating high customer satisfaction and service quality, particularly in tertiary hospitals [1]